Publication Cover
Structural Heart
The Journal of the Heart Team
Volume 4, 2020 - Issue 6
79
Views
3
CrossRef citations to date
0
Altmetric
Original Research - Alternative Access in TAVR and Mechanical Support

The Safety and Efficacy of a Minimalist Approach for Percutaneous Transaxillary Transcatheter Aortic Valve Replacement (TAVR)

, MD, , MD, , MD, , MD & , MBBS, MD (Res.), PhD
Pages 498-503 | Received 03 Apr 2020, Accepted 03 Sep 2020, Published online: 20 Oct 2020
 

ABSTRACT

Background

The safety and efficacy of percutaneous transaxillary transcatheter aortic valve replacement (TAVR) require evaluation. Transfemoral (TF) approach is the standard vascular access for TAVR, but some patients require alternative access due to iliofemoral artery disease. Transaxillary access has been shown to be as safe as TF access. There are limited reports of percutaneous transaxillary TAVR with a minimalist approach.

Methods

Consecutive patients undergoing percutaneous transaxillary TAVR were enrolled. Clinical and procedural characteristics and clinical outcomes were reviewed and compared to TF TAVR performed during the same period.

Results

Among 221 patients who underwent TAVR, 25 patients (11%) had TAVR with a percutaneous transaxillary approach based on computed tomography findings. Median age was 80 years; median STS score was 7%. STS score was higher (7% vs 4%, P = 0.008) and peripheral artery disease was more prevalent (64% vs 13%, P = 0.0001) among patients requiring transaxillary access. Twenty-four (96%) patients underwent the procedure with monitored anesthesia care with pectoral-1 nerve block. Hemostasis was achieved with preapplied ProglideTM closure devices, with an additional closure device in 5 patients (20%). Median length of stay was 3 days, longer than in the TF group (2 days). There was no death, stroke, or major vascular complication. One minor vascular complication required surgical repair. Fluoroscopy time was longer in the transaxillary group than in the TF group (20 vs 16 min, P = 0.0004).

Conclusions

Percutaneous transaxillary TAVR is a safe and effective alternative approach and can be performed with a minimalist approach with outcomes comparable to TF TAVR.

Disclosure statement

Dr. Nikolaos Kakouros is a clinical proctor for Edward Life Science. No potential conflict of interest was reported by the other authors.

Additional information

Funding

The authors have no funding to report for this article.

Log in via your institution

Log in to Taylor & Francis Online

There are no offers available at the current time.

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.